Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating a minor version update to the study record page. This metadata change does not modify the study details.
    Difference
    0.1%
    Check dated 2026-07-04T04:47:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.0 to v3.6.2, reflecting a minor update to the page version without changing its content.
    Difference
    0.1%
    Check dated 2026-06-27T03:18:28.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now includes related topics such as Type 2 diabetes and MedlinePlus Genetics, adding links to genetics-related health information.
    Difference
    0.2%
    Check dated 2026-06-19T22:52:58.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The Study Details page now includes Manfredi Rizzo as part of the study record information and adds new navigation items such as How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment label. Legacy text such as Last known status was, Verified, Manfredi Rizzo, University of Palermo, Intervention / Treatment, and the prior Revision: v3.5.5 has been removed, with Revision: v3.6.0 introduced.
    Difference
    2%
    Check dated 2026-06-12T16:40:08.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page. No actual study data or essential content changes are introduced.
    Difference
    0.1%
    Check dated 2026-06-05T12:07:05.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    Removed the 'Type 2 diabetes' condition from the page’s Conditions section. The related topics header and the MedlinePlus Genetics entry were also removed, affecting navigation and external-resource links.
    Difference
    0.2%
    Check dated 2026-05-29T07:41:08.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.